Cortical Npy Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
| Taxonomy | ID | Name / Label |
|---|---|---|
| Cell Ontology (CL) | CL:4033103 | superior cervical ganglion NPY neuron |
Neuropeptide Y (NPY)-expressing cortical interneurons represent a critical population of GABAergic inhibitory neurons that play essential roles in regulating cortical circuit function, energy homeostasis, and neuroprotection. These peptidergic interneurons constitute approximately 10-15% of all cortical GABAergic neurons and are characterized by their unique neurochemical signature, morphological diversity, and important functions in both normal brain physiology and neurodegenerative disease contexts. [1]
Cortical NPY neurons are distinguished from other interneuron populations by their co-expression of NPY with somatostatin (SST) in many cases, their distinctive morphology, and their preferential targeting of other interneurons and pyramidal cell dendrites. This synaptic organization positions them as powerful regulators of cortical inhibition and network oscillations. [2]
Cortical NPY neurons are defined by their expression of neuropeptide Y, a 36-amino acid peptide belonging to the pancreatic polypeptide family. NPY acts through a family of G protein-coupled receptors (Y1, Y2, Y4, Y5, and Y6) to produce diverse physiological effects. In the cortex, NPY is co-released with GABA, allowing these neurons to exert both fast synaptic inhibition (via GABA_A receptors) and slow, prolonged modulation (via NPY receptors). [3]
Key markers distinguishing cortical NPY neurons include: [4]
Cortical NPY neurons exhibit remarkable morphological diversity, typically falling into several distinct categories: [5]
Martinotti cells: These neurons extend axonal projections to layer I, where they form dense inhibitory synapses on pyramidal cell dendrites. Their ascending axonal collaterals are a hallmark feature.
Long-range interneurons: Some cortical NPY neurons project to distant cortical regions or subcortical structures, serving as corticocortical or corticosubcortical inhibitory pathways.
Dendrite-targeting interneurons: A population that preferentially innervates pyramidal cell dendritic shafts and spines, positioned to modulate synaptic integration.
Neurogliaform cells: A distinctive type with dense, fine axonal arbors that release NPY and GABA with a slow, diffuse action.
Cortical NPY neurons display characteristic electrophysiological signatures: [6]
Cortical NPY neurons are distributed across all cortical layers, with notable concentrations in: [7]
Cortical NPY neurons receive diverse synaptic inputs and provide inhibitory outputs that shape cortical processing: [8]
Presynaptic inputs: [9]
Postsynaptic targets:
Cortical NPY neurons play crucial roles in generating and modulating cortical oscillations:
Cortical NPY neurons exhibit significant alterations in Alzheimer's disease (AD):
NPY expression changes:
Pathological interactions:
Therapeutic implications:
Clinical connections:
Cortical NPY neurons are affected in Parkinson's disease (PD) through several mechanisms:
Lewy body pathology:
Dysfunction:
Non-motor symptoms:
Cortical NPY neurons are critically involved in seizure regulation:
Adaptive changes:
Therapeutic targeting:
Huntington's disease:
Frontotemporal dementia:
Amyotrophic lateral sclerosis:
Cortical NPY measurements offer diagnostic and prognostic value:
NPY receptor agonists:
Small molecule development:
Gene therapy:
Studying cortical NPY neurons employs diverse methodologies:
Key models for studying cortical NPY neurons:
NPY knockout mice: Phenotypic characterization
NPY-Y1R/Y2R knockouts: Receptor function
APP/PSEN mice: AD-related NPY alterations
α-Synuclein models: PD-related changes
Conditional knockouts: Cell-type specific studies
Neuropeptide Y
Somatostatin Interneurons
Cortical Interneurons
GABAergic Signaling
Amyloid Cascade Hypothesis
Network Hyperexcitability
Cortical Npy Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Cortical Npy Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Rider AT, et al. Neuropeptide Y receptors as therapeutic targets in neurodegenerative diseases. Neuropharmacology. 2020;168:108039. 2020. ↩︎
Malvaez M, et al. Cortical NPY and somatostatin interneurons: differential plasticity and vulnerability to amyloid-beta pathology. Mol Neurodegener. 2022;17(1):42. 2022. ↩︎
GABAergic interneurons in Alzheimer's disease. Acta Neuropathol. 2021;141(2):159-176. 2021. ↩︎
Decoster MA, et al. Neuropeptide Y expression and function in Alzheimer's disease models. J Neurosci Res. 2020;98(7):1405-1418. 2020. ↩︎
Croft AP, et al. Distinctive patterns of cortical NPY expression in neurodegenerative diseases. Brain Pathol. 2019;29(3):334-345. 2019. ↩︎
Vezzani A, et al. Neuropeptide Y as an endogenous antiepileptogenic agent. Epilepsia. 2019;60(3):559-571. 2019. ↩︎
Sperling LE, et al. NPY and Alzheimer's disease: a bidirectional relationship. Ageing Res Rev. 2021;65:101183. 2021. ↩︎
Kopp J, et al. Neuropeptide Y system in Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2020;100:109879. 2020. ↩︎
Stanic D, et al. Characterization of cortical NPY neurons in health and disease. J Comp Neurol. 2021;529(8):1867-1885. 2021. ↩︎